Some of them, mainly reported in models of cancer cell lines or transgenic mice [63,82,83], indicate that the blockage of FGFR4 dimerization with antibodies or the use of FGFR4 knock-out mice completely prevented hepatocarcinogenesis [63]. This evidence concerns the gene FGFR4 and cancer.